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Background: Systematic reviews and meta-analyses of pre-clinical studies, in vivo animal experiments in particular,
can influence clinical care. Publication bias is one of the major threats of validity in systematic reviews and meta-
analyses. Previous empirical studies suggested that systematic reviews and meta-analyses have become more
prevalent until 2010 and found evidence for compromised methodological rigor with a trend towards
improvement. We aim to comprehensively summarize and update the evidence base on systematic reviews and
meta-analyses of animal studies, their methodological quality and assessment of publication bias in particular.
Methods/Design: The objectives of this systematic review are as follows:
 To investigate the epidemiology of published systematic reviews of animal studies until present.
 To examine methodological features of systematic reviews and meta-analyses of animal studies with special
attention to the assessment of publication bias.
 To investigate the influence of systematic reviews of animal studies on clinical research by examining citations
of the systematic reviews by clinical studies.
Eligible studies for this systematic review constitute systematic reviews and meta-analyses that summarize in vivo
animal experiments with the purpose of reviewing animal evidence to inform human health. We will exclude
genome-wide association studies and animal experiments with the main purpose to learn more about fundamental
biology, physical functioning or behavior.
In addition to the inclusion of systematic reviews and meta-analyses identified by other empirical studies, we will
systematically search Ovid Medline, Embase, ToxNet, and ScienceDirect from 2009 to January 2013 for further
eligible studies without language restrictions.
Two reviewers working independently will assess titles, abstracts, and full texts for eligibility and extract relevant
data from included studies. Data reporting will involve a descriptive summary of meta-analyses and systematic
reviews.
Discussion: Results are expected to be publicly available later in 2013 and may form the basis for
recommendations to improve the quality of systematic reviews and meta-analyses of animal studies and their use
with respect to clinical care.
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Pre-clinical research has its main purpose in enhancing
our understanding of physiologic and pathologic pro-
cesses. However, many pre-clinical studies, in vivo animal
experiments in particular, may also influence clinical care
of patients through the following mechanisms: i) informa-
tion for the design of clinical studies, ii) clinical guidelines
considering pre-clinical evidence when clinical evidence is
lacking, or iii) direct guidance of clinical practice. For in-
stance, in the widely accepted Surviving Sepsis Guidelines
recommendations regarding target arterial blood pressure
for vasopressor use and positive end-expiratory pressure
in the prevention of lung injury, draw on results from ani-
mal experiments [1]. In addition, a recent empirical study
showed that a substantial number of overviews of animal
experiments investigating therapies for sepsis explicitly ex-
trapolated results from animal studies to human patients
and that subsequent citations of these overviews in publi-
cations of clinical studies reflect the influence of pre-
clinical on clinical research [2].
Whenever a summary of the current evidence is needed
for decision-making in clinical research, health-care policy,
or clinical practice, systematic reviews (SRs) and, where
appropriate, meta-analyses are most useful tools. SRs
offer a structured and transparent way to comprehen-
sively identify and evaluate the available evidence on a
specific topic. Meta-analyses increase the precision and
generalizability of effect estimates by quantitatively
summarizing the results of individual studies included
in an SR in order to provide a single best estimate with
maximal statistical power [3]. SRs and meta-analyses of
pre-clinical studies are still relatively rare in the medical
literature. Mignini and Khan identified 30 SRs of labora-
tory animal experiments in 2006, and Peters et al. found
86 using a more sensitive search strategy and a broader
definition of laboratory animal experiments [4,5]. How-
ever, in an update study Korevaar et al. reported that
SRs of pre-clinical studies are getting more common
over time, doubling their number roughly every 3 years
between 1997 and 2010 [6].
The validity and usefulness of the results of SRs and
meta-analyses strongly depend on their methodological
rigor. Assessing bias, such as publication bias, is essential,
when conducting SRs. If the publication or non-publication
of research findings depends on the nature and direction
of the results (definition of publication bias [7]) then the
published studies are no longer a random sample of all
studies that have been conducted, but constitute a biased
sample leading to spurious summary results. Different
methods have been developed to graphically and statisti-
cally investigate publication bias [8-12]. Although all these
methods have their limitations one should still try to
address the likelihood of publication bias in each SR as
thorough as possible [9,13].While principles of critically appraising SRs of clinical
research are well established, their application to SRs of
pre-clinical studies appears variable [2]. Previous empirical
studies on SRs of animal experiments found that only 16%
(5/30) and 37% (17/46) of meta-analyses considered publi-
cation bias [4,5]. Korevaar et al. reported that between
2005 and 2010 the proportion of meta-analyses of in vivo
animal studies that assessed publication bias increased to
60% (21/35) [6]. A recently published survey conducted
in animal laboratories in the Netherlands reported that
just about 50% of animal experiments are published;
employees of for-profit organizations even estimated
that only 10% of animal experiments appear in peer-
reviewed journals [14]. Lack of statistical significance
was identified as one of several important reasons for
non-publication.
Korevaar et al. conducted their search for SRs of ani-
mal experiments in 2009/10 [6]. It remains unclear how
the number and methodological quality, in particular as-
sessment of publication bias, of such SRs evolved up to
the present (January 2013), and to what extent they are
cited by clinical studies. We will therefore conduct a
comprehensive SR summarizing the results from Peters
et al. and Korevaar et al. and updating the evidence base
for SRs of animal experiments. This SR will be part of
the project, To Overcome failure to Publish nEgative
fiNdings (OPEN Project), which was developed with the
goal of elucidating the scope of publication bias and
non-publication of studies through a series of SRs and
policy evaluations (www.open-project.eu).
Objectives
The specific goals of the present SR of animal studies
are: determining the number of published SRs of animal
studies up to the present; investigating methodological
features of SRs and meta-analyses of animal studies es-
pecially with respect to assessment of publication bias,
and investigating the influence of SRs of animal studies
on clinical research by examining citations of the SRs in
clinical studies.
Methods
Eligibility criteria
To allow for a valid combination of results we will use
similar criteria and search strategies to Peters et al. and
Korevaar et al. [5,6], to identify relevant SRs and meta-
analyses of animal experiments. We will consider an art-
icle an SR if it provides details on the source(s) of evidence
searched and information on at least one of the following:
i) search terms used, ii) any limitation placed on the
search, or iii) inclusion and exclusion criteria. In addition,
we will use a second, more stringent, definition of an SR
requiring besides a systematic search and explicit inclusion
and exclusion criteria, also a focused research question
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studies [15]. For meta-analyses, a review has to report on
some form of quantitative synthesis of results of more
than one animal experiment. SRs and meta-analyses will
be included if they summarize in vivo animal experiments
with the purpose of reviewing animal evidence to inform
human health and if they can be allocated to one of the
following categories: i) investigation of the efficacy of a
medical or surgical intervention; ii) investigation of the
side-effects or toxicity of a medical intervention; iii) in-
vestigation of the mechanisms of action of a medical
intervention; iv) investigation of risk factors (epidemio-
logical associations or mechanisms of action of disease);
v) investigation of effects of an exposure to a chemical
substance; vi) overview of animal models for disease,
and vii) investigation of diagnostic test accuracy. Arti-
cles including human studies in addition to animal stud-
ies will be considered too. As did Korevaar et al. we will
exclude genome-wide association studies and animal ex-
periments with the main purpose to learn more about
fundamental biology, physical functioning or behavior
and not to inform human healthcare.
Search strategy
We will systematically search electronic databases such as
Ovid Medline, Embase, Toxnet (http://toxnet.nlm.nih.gov/;
including Toxline, DART, and HSDB) and ScienceDirect,
all from 2009 to the present (January 2013). In addition,
the bibliographies of any eligible articles identified will be
checked for additional references. No language restrictions
will be applied. The search strategy used by Korevaar et al.
has been slightly modified with the support of a librarian/
information specialist. The full search strategies are
displayed in Additional file 1. We will not search any grey
literature (that is, literature that has not been formally
published).Study selection
Two reviewers will independently and in duplicate screen
titles and abstracts of search results. If a title and abstract
cannot be rejected with certainty by both reviewers, the
full text of the paper will be retrieved and assessed for eli-
gibility. Any disagreements among reviewers will be re-
solved by discussion and consensus or, if needed, third
party arbitration.
Data extraction
A specifically designed data extraction form will be devel-
oped and pilot-tested. Working in teams of two, we will
independently extract relevant information from each eli-
gible article. From all eligible SRs (those included in Peters
et al. or Korevaar et al. plus those identified through our
search update) we will abstract the following: first authorand publication year; journal (goal: distinguish clinical
from other journals); whether the article identifies itself as
an SR or meta-analysis in the title or abstract; the objec-
tive; search strategy (how many and which electronic data-
bases, language restrictions, if any grey literature was
searched, if yes, which and how); whether any formal as-
sessment of study quality was performed, and which in-
strument was used; number of included studies; whether
any funding sources were reported for the SR and ab-
stracted from the included studies; whether any assess-
ment of the presence of publication bias was reported, and
which method was used; any other comments on publica-
tion bias; whether any reporting guideline (QUOROM,
PRISMA) for SRs was mentioned.
From meta-analyses we will additionally extract the
following data: number of included studies and total
number of experiments; number and species of animals
used; whether intention to treat was mentioned; whether
effect estimates from individual studies were reported;
which method was used for data synthesis; whether het-
erogeneity was assessed.
Any disagreements will be resolved by discussion and
consensus or, if needed, third party arbitration. We will
use the ISI Web of Science Internet-based citation data-
base to identify clinical publications citing included
animal SRs. We will not do this for all included SRs but
will rather focus on the following sample: SRs with meta-
analysis published between 2005 and 2009 (29 articles)
and a random sample of 29 SRs without meta-analysis.
Limiting to articles published until 2009 allows all articles
to be available in the literature for at least 3 years until our
analysis. We will focus on studies likely to influence
clinical decision making, such as i) randomized con-
trolled trials; ii) matched controlled trials; iii) crossover
trials; iv) uncontrolled prospective trials; v) guidelines;
vi) retrospective cohort studies; vii) prospective cohort
studies; viii) laboratory experiments with healthy human
volunteers; ix) cross-sectional surveys, and x) case re-
port/case series. Two reviewers will review each of the
58 studies independently and in duplicate. They will
abstract the role of the citation by allocating a citation
to one of the following categories: i) use of citation
unrelated to animal studies in review; ii) used citation
to provide at least partial justification for the study or a
future study; iii) used citation to support or explain
their findings; iv) used citation to discuss physiological
pathways, and v) used citation to justify the measure of
certain variables.Data reporting
Data reporting will involve a descriptive summary of
meta-analyses and systematic reviews. We will report
the study according to PRISMA guidelines [16].
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This SR aims to comprehensively summarize the epi-
demiology and methodological quality of SRs and meta-
analyses of in vivo animal studies with special attention
to the assessment of publication bias. SRs of animal
studies can influence clinical care directly or indirectly
through guidelines and clinical studies that are designed
based on evidence from pre-clinical studies. In order to
better understand the extent of that influence we plan
to examine citations of identified reviews in publications
of clinical studies.
Our protocol has strengths and limitations. The strengths
are that we will use a comprehensive approach to iden-
tify SRs and meta-analyses of in vivo animal studies
through a sensitive search strategy and inclusion of pre-
viously identified articles. We will employ two defini-
tions of SRs: a broader one that ensures comparability
with previous empirical studies and a more stringent
definition that will be applied to all articles meeting the
broader criteria. A limitation of our protocol is that our
results might be affected by publication bias because we
will not search any grey literature. We are therefore limit-
ing the generalizability of our results about methodo-
logical quality and publication bias to the published SRs of
in vivo animal studies.
This SR together with the results of other SRs in the
context of the OPEN Project will raise awareness about
the widespread plague of publication bias and the com-
plexity of this issue. Moreover, these reviews will serve
as a foundation for a recommendations workshop, which
will enable key members of the biomedical research
community (for example, funders, research ethics commit-
tees, journal editors, et cetera.) to develop future policies
and guidelines to reduce the frequency of non-publication
and related biases.Additional file
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